TLR4 single nucleotide polymorphisms and thrombosis risk in patients with myeloproliferative disorders

Thromb Res. 2008;122(1):27-32. doi: 10.1016/j.thromres.2007.09.016. Epub 2007 Nov 14.

Authors

M Speletas¹, K Liadaki, F Kalala, C Daiou, E Katodritou, E Mandala, I Korantzis, K Ritis, E Zintzaras, A E Germenis

Affiliation

¹ Department of Immunology and Histocompatibility, School of Medicine, University Hospital of Thessaly, Larissa, 41110 Larissa, Greece. maspel@med.uth.gr

PMID: 17999935
DOI: 10.1016/j.thromres.2007.09.016

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Bone Marrow Cells / pathology
DNA / genetics
DNA / isolation & purification
Female
Genotype
Humans
Male
Middle Aged
Myeloproliferative Disorders / complications
Myeloproliferative Disorders / genetics*
Polymorphism, Single Nucleotide*
Risk Factors
Thrombosis / epidemiology*
Thrombosis / genetics*
Toll-Like Receptor 4 / genetics*

Substances

TLR4 protein, human
Toll-Like Receptor 4
DNA